Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2024.1508146 Endocrinology Correction Corrigendum: Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features Soares Reivla Marques Vasconcelos 1 da Silva Monique Alvares 2 Campos Julliane Tamara Araújo de Melo 2 3 Lima Josivan Gomes 1 * 1 Department of Clinical Medicine, Hospital Universitaírio Onofre Lopes (HUOL), Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil 2 Molecular Biology and Genomics Laboratory, Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil 3 Department of Morphology (DMOR), Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Josivan Gomes Lima, josivanlima@gmail.com

03 12 2024 2024 15 1508146 08 10 2024 29 10 2024 Copyright © 2024 Soares, da Silva, Campos and Lima 2024 Soares, da Silva, Campos and Lima

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features By Soares RMV, da Silva MA, Campos JTAdM and Lima JG (2024). Front. Endocrinol. 15:1394102. doi: 10.3389/fendo.2024.1394102 PPAR gamma adipose tissue genetic lipodystrophy insulin resistance diabetes mellitus section-in-acceptance Clinical Diabetes

In the published article, there was an error in the Funding statement. The Funding statement was displayed as “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001”. The correct Funding statement appears below.

“The authors declare that financial support was received for manuscript processing charges and the open access fee from Chiesi Global Rare Diseases (GRD). Chiesi GRD was not involved in the design, data collection, interpretation or decision to publish this manuscript.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.